HLS Therapeutics Stock (OTC: HLTRF) stock price, news, charts, stock research, profile.
|Vol / Avg.0 / 3.081K||Mkt Cap87.980M|
|Day Range- - -||52 Wk Range2.600 - 7.680|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2021-08-06||Raymond James||-||Downgrades||OutperformMarket Perform||-||-||-|
You can purchase shares of HLS Therapeutics (OTCPK: HLTRF) through any online brokerage.
There are no as such competitors for HLS Therapeutics.
The latest price target for HLS Therapeutics (OTCPK: HLTRF) was reported by Raymond James on Friday, August 6, 2021. The analyst firm set a price target for 0.00 expecting HLTRF to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for HLS Therapeutics (OTCPK: HLTRF) is $2.7433 last updated November 20, 2023 at 8:34 PM UTC.
A quarterly cash dividend of $0.04 per share of Class A Common Stock. The quarterly cash dividend was payable on December 14, 2018 to stockholders of record on October 23, 2018.
HLS Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for HLS Therapeutics.
HLS Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.